LITFULO Trademark

Trademark Overview

On Thursday, May 20, 2021, a trademark application was filed for LITFULO with the United States Patent and Trademark Office. The USPTO has given the LITFULO trademark a serial number of 90723569. The federal status of this trademark filing is REGISTERED as of Tuesday, December 12, 2023. This trademark is owned by Pfizer Inc.. The LITFULO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of alopecia areata
litfulo

General Information

Serial Number90723569
Word MarkLITFULO
Filing DateThursday, May 20, 2021
Status700 - REGISTERED
Status DateTuesday, December 12, 2023
Registration Number7243324
Registration DateTuesday, December 12, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of alopecia areata

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 17, 2021
Primary Code005
First Use Anywhere DateMonday, July 31, 2023
First Use In Commerce DateMonday, July 31, 2023

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, December 12, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 12, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, November 8, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 7, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, October 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 27, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 18, 2023USE AMENDMENT FILED
Friday, October 27, 2023SOU EXTENSION 3 GRANTED
Wednesday, October 18, 2023SOU EXTENSION 3 FILED
Friday, October 27, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 18, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 18, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, April 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 17, 2023SOU EXTENSION 2 GRANTED
Monday, April 17, 2023SOU EXTENSION 2 FILED
Monday, April 17, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 28, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 7, 2022SOU EXTENSION 1 GRANTED
Friday, October 7, 2022SOU EXTENSION 1 FILED
Friday, October 7, 2022SOU TEAS EXTENSION RECEIVED
Friday, May 27, 2022ASSIGNED TO EXAMINER
Tuesday, April 26, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 1, 2022PUBLISHED FOR OPPOSITION
Wednesday, February 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 27, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 21, 2022ASSIGNED TO EXAMINER
Tuesday, August 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 24, 2021NEW APPLICATION ENTERED

Related Keywords

litfulo pharmaceutical treatment preparations areata alopecia autoimmune diseases disorders